In vitro experiments, animal experiments, and clinical trials have all confirmed that integrating MSCs into the treatment of T1DM may achieve pancreatic β-cell regeneration and normalization of insulin metabolism [24]. Here, INS is linked to type 1 diabetes mellitus.